Skip to main content
Premium Trial:

Request an Annual Quote

Decode Genetics' Stock to be Suspended on Nasdaq Tomorrow

NEW YORK (GenomeWeb News) – Decode Genetics has received notification from the Nasdaq Stock Market that the firm's common stock will be suspended from trading as of the open of business tomorrow.

The Iceland-based firm also said that documents will be filed with the US Securities and Exchange Commission, which will remove the firm's common stock from listing on Nasdaq.

Decode said that it is possible its stock will be traded thereafter on the Pink Sheets, but that depends if there is a market maker for the shares.

The firm received a delisting notice from Nasdaq in November, following its filing for Chapter 11 bankruptcy protection.

The Scan

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.

EHR Quality Improvement Study Detects Demographic-Related Deficiencies in Cancer Family History Data

In a retrospective analysis in JAMA Network Open, researchers find that sex, ethnicity, language, and other features coincide with the quality of cancer family history information in a patient's record.

Inflammatory Bowel Disease Linked to Gut Microbiome Community Structure Gradient in Meta-Analysis

Bringing together data from prior studies, researchers in Genome Biology track down microbial taxa and a population structure gradient with ties to ulcerative colitis or Crohn's disease.

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.